EFFECT OF PIOGLITAZONE TREATMENT ON THE PROGRESSION OF IMPAIRED GLUSCOSE TOLERAN

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究是关于用吡格列酮治疗糖耐量受损的个体是否可以预防或延缓2型糖尿病的发展。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is an examination of whether treatment of individuals with impaired glucose tolerance with pioglitazone can prevent or delay the development of type 2 diabetes mellitus.